美国达尔令国际旗下健康品牌Rousselot获美国专利,推出首款支持血糖调节的胶原蛋白肽配方Nextida® GC

美股速递
Jun 04

美国达尔令国际旗下健康品牌Rousselot成功获得一项美国专利,该专利涉及名为Nextida® GC的胶原蛋白肽配方。据悉,这是全球首款经证实能够支持人体血糖调节的胶原蛋白肽成分。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10